Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity
Authors:
Open Access
- 1 March 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (15) , 24694-24705
Abstract
Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunity Interferon alpha antagonizes the anti-hepatoma activity of the oncolytic virus M1 by stimulating anti-viral immunityKeywords
This publication has 30 references indexed in Scilit:
- Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defenseBMC Cancer, 2011
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977Journal of Biological Chemistry, 2010
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effectNature, 2010
- Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen–positive patients after liver transplantationLiver Transplantation, 2009
- Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 proteinCell Cycle, 2009
- Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathwaysExpert Opinion on Biological Therapy, 2009
- Nonclinical Safety Profile of Telbivudine, a Novel Potent Antiviral Agent for Treatment of Hepatitis BAntimicrobial Agents and Chemotherapy, 2008
- VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon CellsAntimicrobial Agents and Chemotherapy, 2006
- Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 2005
- Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In VitroThe Journal of Infectious Diseases, 1996